Li, Ke
Xu, Jing
Wang, Jing
Lu, Chong
Dai, Yilin
Dai, Qing
Zhang, Wang
Xu, Congjian
Wu, Shu
Kang, Yu http://orcid.org/0000-0003-1197-4727
Funding for this research was provided by:
National Key R&D Program of China (2016YFC1303100, 2016YFC1303102)
Shanghai Shenkang Hospital Development Center (SHDC12018X13)
Shanghai Municipal Health and Family Planning Commission (2018BR26)
Shanghai Science and Technology Commission (18140902502, 18411963300)
Article History
Received: 22 February 2021
Accepted: 2 September 2022
First Online: 27 September 2022
Change Date: 18 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00262-024-03668-8
Declarations
:
: No conflicts.
: All animal experiments were performed according to the Ethics Committee of Department of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University (Shanghai, China). The applied of human T cells and the human ovarian cancer tissues was approved by the patients and the Ethics Committee of Department of Obstetrics and Gynaecology, Shanghai Medical School, Fudan University (Shanghai, China).
: Female NCG mice were purchased from GemPharmatech Co., Ltd. (Jiangsu, China).